New Protocol Advances Toward Lab-Made Universal Red Blood Cells
New Protocol Advances Toward Lab-Made Universal Red Blood Cells
Researchers report a new way of generating the cells from induced pluripotent stem cells in hopes they will one day be used in blood transfusions.
New Protocol Advances Toward Lab-Made Universal Red Blood Cells
New Protocol Advances Toward Lab-Made Universal Red Blood Cells

Researchers report a new way of generating the cells from induced pluripotent stem cells in hopes they will one day be used in blood transfusions.

Researchers report a new way of generating the cells from induced pluripotent stem cells in hopes they will one day be used in blood transfusions.

induced pluripotent stem cell
Oct4, Considered Vital for Creating iPSCs, Actually Isn’t Needed
Oct4, Considered Vital for Creating iPSCs, Actually Isn’t Needed
Emma Yasinski | Nov 8, 2019
Dropping the transcription factor from the four so-called Yamanaka factors reduces the efficiency of inducing the production of stem cells, but the resulting cells are of greater quality.
Bioethicists Concerned over Japan’s Chimera Embryo Regulations
Bioethicists Concerned over Japan’s Chimera Embryo Regulations
Katarina Zimmer | Apr 4, 2019
Many researchers see the move to relax the rules as a welcome change, yet some are worried the revisions don’t take public concerns enough into consideration.
Opinion: Ethical Challenges in Using iPS Cells to Treat Paralysis
Opinion: Ethical Challenges in Using iPS Cells to Treat Paralysis
John D. Loike, Martin Grumet | Mar 7, 2019
Uncertainties about the cells’ risk profiles and the potential for hyping unproven therapies mean scientists and the media must tread carefully.
Stem Cell–Derived Neurons from People with Autism Grow Differently
Stem Cell–Derived Neurons from People with Autism Grow Differently
Jef Akst | Jan 11, 2019
Changes in gene expression also hint at how the brains of people with ASD develop differently from those of other people.
Increasing Number of iPS Cell Therapies Tested in Clinical Trials
Increasing Number of iPS Cell Therapies Tested in Clinical Trials
Katarina Zimmer | Nov 28, 2018
Since their discovery in 2006, induced pluripotent stem cells have been poised to reprogram regenerative medicine. Twelve years on, here’s how far they’ve come.
Parkinson’s Patient Transplanted with Neurons Derived from iPSCs
Parkinson’s Patient Transplanted with Neurons Derived from iPSCs
Ashley P. Taylor | Nov 14, 2018
This is the first time researchers have tested the use of the reprogrammed stem cells in the human brain.
First iPS Cell Trial for Heart Disease Raises Excitement, Concern
First iPS Cell Trial for Heart Disease Raises Excitement, Concern
Katarina Zimmer | Aug 31, 2018
Without knowing the cells’ mechanism of action, researchers question the best way to administer them to patients.
World’s First Commercial iPSC Cell Plant Opens in Japan
World’s First Commercial iPSC Cell Plant Opens in Japan
Jim Daley | Mar 23, 2018
The $340 million, 30,000-square-foot center will produce cells for therapeutic applications.
Stem Cells Made by Modifying the Epigenome with CRISPR
Stem Cells Made by Modifying the Epigenome with CRISPR
Abby Olena | Jan 25, 2018
Researchers use the technique to turn on Oct4 or Sox2 in mouse embryonic fibroblasts and convert them into pluripotent cells.